Key U.S. Lawmaker Announces Investigation into Chinese Illicit Vape Manufacturers, Signaling Potential Regulatory Shake-Up

Dec.03.2024
 Key U.S. Lawmaker Announces Investigation into Chinese Illicit Vape Manufacturers, Signaling Potential Regulatory Shake-Up
On December 2, a leading U.S. lawmaker with a pivotal role in U.S.-China trade relations unveiled a series of new measures to address the youth vaping crisis, including an investigation into Chinese illicit e-cigarette manufacturers. Given the Congressman’s history of shaping e-cigarette regulation and his influence in trade policy, the move signals the potential for significant shifts in U.S. vaping regulations.

Disclaimer:

 

1. This article solely addresses issues of e-cigarette regulation and commerce, intended for readers within the global next-generation tobacco industry.

2. The content does not analyze or comment on political or diplomatic matters. Nothing herein may be cited for political or diplomatic purposes.

3. Opinions and remarks from individuals referenced in this article are conveyed objectively and do not reflect the views of 2Firsts. No judgment is made on their perspectives in other domains.

4. Statements related to politics and diplomacy are based on official declarations.

 

[Reported by 2Firsts] According to an announcement published on the U.S. House of Representatives website, on December 2, 2024, Chicago time, Raja Krishnamoorthi, the Ranking Member of the Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party, joined local officials in discussing efforts to combat youth vaping. During the meeting, he announced a new investigation into Chinese illicit vape manufacturers. Key points from the announcement include:

 

  • Approximately 95% of global vaping products are manufactured in China, including popular brands such as Elf Bar. Despite this, the U.S. Food and Drug Administration (FDA) has authorized only 34 tobacco-flavored e-cigarette products for sale nationwide. (Original text reads "tobacco-flavored e-cigarette products". In fact, on June 21, 2024, the FDA approved four menthol-flavored e-cigarette products from NJOY for the first time. Note by 2Firsts.)

 

  • A U.S. county sheriff stated, "Like the opioid crisis, the unrelenting flood of toxic vaping devices, flavored like candy and marketed to appeal to youth, is a public health crisis that demands federal resources and solutions."

 

  • Krishnamoorthi urged the FDA to act decisively to remove all illicit vaping products from shelves in Cook County, across Illinois, and throughout the United States.

 

  • Throughout his tenure, Krishnamoorthi has advocated for stricter regulations on e-cigarettes and vaping products, including his 2019 investigation into JUUL, which uncovered targeted advertising aimed at youth. He also co-chairs the bipartisan Congressional Caucus to End the Youth Vaping Epidemic.

 

On the same day, Congressman Raja Krishnamoorthi took to social media platform X to criticize Big Tobacco and illicit e-cigarette manufacturers for targeting children. He also urged the FDA to take swift action to address the issue.

 

 Key U.S. Lawmaker Announces Investigation into Chinese Illicit Vape Manufacturers, Signaling Potential Regulatory Shake-Up
Congressman Raja Krishnamoorthi’s Social Media Post on X |Image source: X

 

 

Youth Vaping and Illicit E-Cigarettes Under Scrutiny

 

 

In recent months, U.S. attention on youth vaping and illicit e-cigarette concerns has intensified.

 

In October 2024, the FDA and Customs and Border Protection (CBP) seized approximately 3 million unauthorized e-cigarette products with an estimated retail value of $76 million—the largest financial seizure of its kind to date.

 

That same month, 2Firsts corresponded with the FDA regarding regulatory policies. In its response, the FDA emphasized that only 34 e-cigarette products are currently authorized for legal sale and provided a comprehensive list of approved products. View the full list here.

 

In November, a U.S. research organization reported a 500% increase in disposable vape sales between 2019 and 2023, making them the most popular device among youth. As of March 2024, the 34 FDA-authorized products accounted for just 13.7% of total retail sales in the U.S.

 

 

International Cooperation on E-Cigarette Regulation Gains Diplomatic Traction

 

 

Collaboration on e-cigarette regulation has expanded into the realm of diplomacy.

 

In June 2024, during a meeting between the Chinese and Australian prime ministers, a joint statement was released emphasizing cooperation on border enforcement, including the fight against illicit tobacco and e-cigarette smuggling. This marked the first time such issues were explicitly mentioned in a bilateral statement.

 

Leading up to this meeting, there were multiple high-level engagements between regulatory and enforcement agencies from both nations. For example, on May 6, 2024, Chinese officials(STMA) met with Australia's Deputy Commissioner of Border Enforcement to discuss collaborative measures.

 

2Firsts will continue to track these developments and provide in-depth coverage on the evolving landscape of global e-cigarette regulation.

 

We welcome tips and comments. Please contact us at info@2firsts.com, or connect with 2Firsts CEO Alan Zhao on LinkedIn (here).

 

Cover image: NBC Chicago's News Coverage on the Matter | Image Source: NBC Chicago

 

Senate Democrat Wyden Probes Trump Administration Vape Policy Shift, Seeks Records From HHS and Reynolds American
Senate Democrat Wyden Probes Trump Administration Vape Policy Shift, Seeks Records From HHS and Reynolds American
U.S. Senator Ron Wyden, the Democratic ranking member of the Senate Finance Committee, has launched an investigation into flavored vape policy changes and requested records from the Department of Health and Human Services (HHS), Reynolds American and Botanic Tonics. The investigation focuses on a timeline involving Reynolds American’s $5 million donation to MAGA Inc. in April 2026 and subsequent vape policy developments. Wyden said the review aims to examine potential links between political donations, corporate communications and government decisions. The investigation does not represent a finding of wrongdoing.
Innovation
Aug.07 by 2Firsts Perspectives
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
China’s Zhengzhou Tobacco Research Institute develops end-to-end heated tobacco analysis to trace aerosol compound origins
China’s Zhengzhou Tobacco Research Institute develops end-to-end heated tobacco analysis to trace aerosol compound origins
The Zhengzhou Tobacco Research Institute of China National Tobacco Corporation has filed a patent application for an end-to-end method to analyze the migration and transformation of chemical compounds in heated tobacco products. Using GC-Orbitrap/MS non-targeted analysis, the method compares tobacco substrate and aerosol samples to distinguish compounds transferred directly from the substrate from those newly formed during heating, while also calculating transfer rates. In an example involving nine heated tobacco products, the patent identified 17 newly formed thermal decomposition compounds and 38 transferred compounds.
Aug.13
Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
British American Tobacco Japan (BAT Japan) expanded VELO Peach Ice Medium to FamilyMart stores nationwide in Japan from September 7, 2026. The oral tobacco product first launched on July 6 and had previously been sold through VELO's official online store, glo Store Ginza and tobacco retailers. It combines peach flavor with menthol cooling at a Medium strength level and is priced at JPY 360. Japanese tobacco retailers list 15 pouches per pack. The move adds the new SKU to an existing nationwide FamilyMart distribution network for VELO rather than marking the brand's first entry into the convenience-store chain.
Sep.15
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Jiangsu Provincial Medical Products Administration have issued a joint notice targeting illegal production and sales of vape products disguised as medical devices. The notice identifies six categories of violations, including obtaining medical licenses through false materials, misusing medical device credentials, expanding production beyond approved scopes, and using medical device-related online platforms to promote or sell vape products. The action is based on China’s tobacco and medical device regulations and aims to strengthen vape oversight and consumer protection.
Aug.04
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14